£750K
Giles AI secures £750k in pre-seed funding to scale its healthcare artificial intelligence platform.
The pre-seed round was backed by Regulatory Scientific and Health Solutions and angel investors to support product development and team growth.
"We founded Giles AI to dramatically accelerate clinical and medical research using secure, cutting-edge, conversational AI. The impact is transformative: a typical 10-year, $1.5bn drug or device development pipeline can be accelerated significantly – getting life-saving innovations to market faster than ever before. With our collaboration with Google, our recent £750K pre-seed raise gives us the runway to scale rapidly -FounderCatalyst were instrumental facilitating the raise, providing expert legal guidance and an incredibly efficient process that let us stay focused on building the future of medical research."